Vaccination in pregnancy.
Identifieur interne : 001041 ( PubMed/Curation ); précédent : 001040; suivant : 001042Vaccination in pregnancy.
Auteurs : Karin A. Fox [États-Unis] ; Regan TheilerSource :
- Current pharmaceutical biotechnology [ 1873-4316 ] ; 2011.
Descripteurs français
- KwdFr :
- Animaux, Complications de la grossesse et maladies infectieuses (), Complications de la grossesse et maladies infectieuses (immunologie), Complications de la grossesse et maladies infectieuses (métabolisme), Complications de la grossesse et maladies infectieuses (virologie), Femelle, Grippe humaine (), Grippe humaine (immunologie), Grippe humaine (métabolisme), Grossesse, Humains, Vaccination (), Vaccins antigrippaux (immunologie), Vaccins antigrippaux (pharmacocinétique), Vaccins atténués (immunologie), Vaccins atténués (pharmacocinétique), Échange foetomaternel.
- MESH :
- immunologie : Complications de la grossesse et maladies infectieuses, Grippe humaine, Vaccins antigrippaux, Vaccins atténués.
- métabolisme : Complications de la grossesse et maladies infectieuses, Grippe humaine.
- pharmacocinétique : Vaccins antigrippaux, Vaccins atténués.
- virologie : Complications de la grossesse et maladies infectieuses.
- Animaux, Complications de la grossesse et maladies infectieuses, Femelle, Grippe humaine, Grossesse, Humains, Vaccination, Échange foetomaternel.
English descriptors
- KwdEn :
- Animals, Female, Humans, Influenza Vaccines (immunology), Influenza Vaccines (pharmacokinetics), Influenza, Human (immunology), Influenza, Human (metabolism), Influenza, Human (prevention & control), Maternal-Fetal Exchange, Pregnancy, Pregnancy Complications, Infectious (immunology), Pregnancy Complications, Infectious (metabolism), Pregnancy Complications, Infectious (prevention & control), Pregnancy Complications, Infectious (virology), Vaccination (methods), Vaccines, Attenuated (immunology), Vaccines, Attenuated (pharmacokinetics).
- MESH :
- chemical , immunology : Influenza Vaccines, Vaccines, Attenuated.
- chemical , pharmacokinetics : Influenza Vaccines, Vaccines, Attenuated.
- immunology : Influenza, Human, Pregnancy Complications, Infectious.
- metabolism : Influenza, Human, Pregnancy Complications, Infectious.
- methods : Vaccination.
- prevention & control : Influenza, Human, Pregnancy Complications, Infectious.
- virology : Pregnancy Complications, Infectious.
- Animals, Female, Humans, Maternal-Fetal Exchange, Pregnancy.
Abstract
The recent H1N1 influenza pandemic has highlighted the potential for viral infections to cause severe disease in mothers disproportionate to the general population and have deleterious effects on the fetus. Vaccines have been used in pregnant women for over 200 years. Current guidelines recommend vaccination with only inactivated virus due to potential risk to mother and fetus with live vaccine. The exception is during times of pandemic or biological weapons attack, when the risk of life-threatening disease outweighs the risk of vaccination. A paucity of data is available regarding actual risk and mechanisms of live viral vaccine transfer from mother to fetus. Pregnancy-induced changes to the maternal immune system, effects of maternal infection on neonatal immunity, and the role of the placenta in transmission of infection and passive immunity to the fetus are incompletely understood. The aim of this paper is to review available data pertaining to newer vaccines such as the pandemic H1N1 and HPV vaccines in pregnancy, the role of Fc receptors in active transport of immunoglobulin across the placenta, and cytokine activity during maternal infection and after vaccination. We will also discuss potential areas for future research.
DOI: 10.2174/138920111795471001
PubMed: 21480828
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001041
Links to Exploration step
pubmed:21480828Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Vaccination in pregnancy.</title><author><name sortKey="Fox, Karin A" sort="Fox, Karin A" uniqKey="Fox K" first="Karin A" last="Fox">Karin A. Fox</name><affiliation wicri:level="1"><nlm:affiliation>Department of Obstetrics and Gynecology, University of Texas Medical Branch at Galveston, Galveston, TX 77550, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Obstetrics and Gynecology, University of Texas Medical Branch at Galveston, Galveston, TX 77550</wicri:regionArea></affiliation></author><author><name sortKey="Theiler, Regan" sort="Theiler, Regan" uniqKey="Theiler R" first="Regan" last="Theiler">Regan Theiler</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2011">2011</date><idno type="RBID">pubmed:21480828</idno><idno type="pmid">21480828</idno><idno type="doi">10.2174/138920111795471001</idno><idno type="wicri:Area/PubMed/Corpus">001041</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001041</idno><idno type="wicri:Area/PubMed/Curation">001041</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001041</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Vaccination in pregnancy.</title><author><name sortKey="Fox, Karin A" sort="Fox, Karin A" uniqKey="Fox K" first="Karin A" last="Fox">Karin A. Fox</name><affiliation wicri:level="1"><nlm:affiliation>Department of Obstetrics and Gynecology, University of Texas Medical Branch at Galveston, Galveston, TX 77550, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Obstetrics and Gynecology, University of Texas Medical Branch at Galveston, Galveston, TX 77550</wicri:regionArea></affiliation></author><author><name sortKey="Theiler, Regan" sort="Theiler, Regan" uniqKey="Theiler R" first="Regan" last="Theiler">Regan Theiler</name></author></analytic><series><title level="j">Current pharmaceutical biotechnology</title><idno type="eISSN">1873-4316</idno><imprint><date when="2011" type="published">2011</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Female</term><term>Humans</term><term>Influenza Vaccines (immunology)</term><term>Influenza Vaccines (pharmacokinetics)</term><term>Influenza, Human (immunology)</term><term>Influenza, Human (metabolism)</term><term>Influenza, Human (prevention & control)</term><term>Maternal-Fetal Exchange</term><term>Pregnancy</term><term>Pregnancy Complications, Infectious (immunology)</term><term>Pregnancy Complications, Infectious (metabolism)</term><term>Pregnancy Complications, Infectious (prevention & control)</term><term>Pregnancy Complications, Infectious (virology)</term><term>Vaccination (methods)</term><term>Vaccines, Attenuated (immunology)</term><term>Vaccines, Attenuated (pharmacokinetics)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Complications de la grossesse et maladies infectieuses ()</term><term>Complications de la grossesse et maladies infectieuses (immunologie)</term><term>Complications de la grossesse et maladies infectieuses (métabolisme)</term><term>Complications de la grossesse et maladies infectieuses (virologie)</term><term>Femelle</term><term>Grippe humaine ()</term><term>Grippe humaine (immunologie)</term><term>Grippe humaine (métabolisme)</term><term>Grossesse</term><term>Humains</term><term>Vaccination ()</term><term>Vaccins antigrippaux (immunologie)</term><term>Vaccins antigrippaux (pharmacocinétique)</term><term>Vaccins atténués (immunologie)</term><term>Vaccins atténués (pharmacocinétique)</term><term>Échange foetomaternel</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Influenza Vaccines</term><term>Vaccines, Attenuated</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacokinetics" xml:lang="en"><term>Influenza Vaccines</term><term>Vaccines, Attenuated</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Complications de la grossesse et maladies infectieuses</term><term>Grippe humaine</term><term>Vaccins antigrippaux</term><term>Vaccins atténués</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Influenza, Human</term><term>Pregnancy Complications, Infectious</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Influenza, Human</term><term>Pregnancy Complications, Infectious</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Vaccination</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Complications de la grossesse et maladies infectieuses</term><term>Grippe humaine</term></keywords><keywords scheme="MESH" qualifier="pharmacocinétique" xml:lang="fr"><term>Vaccins antigrippaux</term><term>Vaccins atténués</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Influenza, Human</term><term>Pregnancy Complications, Infectious</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Complications de la grossesse et maladies infectieuses</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Pregnancy Complications, Infectious</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Female</term><term>Humans</term><term>Maternal-Fetal Exchange</term><term>Pregnancy</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Complications de la grossesse et maladies infectieuses</term><term>Femelle</term><term>Grippe humaine</term><term>Grossesse</term><term>Humains</term><term>Vaccination</term><term>Échange foetomaternel</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The recent H1N1 influenza pandemic has highlighted the potential for viral infections to cause severe disease in mothers disproportionate to the general population and have deleterious effects on the fetus. Vaccines have been used in pregnant women for over 200 years. Current guidelines recommend vaccination with only inactivated virus due to potential risk to mother and fetus with live vaccine. The exception is during times of pandemic or biological weapons attack, when the risk of life-threatening disease outweighs the risk of vaccination. A paucity of data is available regarding actual risk and mechanisms of live viral vaccine transfer from mother to fetus. Pregnancy-induced changes to the maternal immune system, effects of maternal infection on neonatal immunity, and the role of the placenta in transmission of infection and passive immunity to the fetus are incompletely understood. The aim of this paper is to review available data pertaining to newer vaccines such as the pandemic H1N1 and HPV vaccines in pregnancy, the role of Fc receptors in active transport of immunoglobulin across the placenta, and cytokine activity during maternal infection and after vaccination. We will also discuss potential areas for future research.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21480828</PMID><DateCompleted><Year>2011</Year><Month>09</Month><Day>12</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>18</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1873-4316</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>5</Issue><PubDate><Year>2011</Year><Month>May</Month></PubDate></JournalIssue><Title>Current pharmaceutical biotechnology</Title><ISOAbbreviation>Curr Pharm Biotechnol</ISOAbbreviation></Journal><ArticleTitle>Vaccination in pregnancy.</ArticleTitle><Pagination><MedlinePgn>789-96</MedlinePgn></Pagination><Abstract><AbstractText>The recent H1N1 influenza pandemic has highlighted the potential for viral infections to cause severe disease in mothers disproportionate to the general population and have deleterious effects on the fetus. Vaccines have been used in pregnant women for over 200 years. Current guidelines recommend vaccination with only inactivated virus due to potential risk to mother and fetus with live vaccine. The exception is during times of pandemic or biological weapons attack, when the risk of life-threatening disease outweighs the risk of vaccination. A paucity of data is available regarding actual risk and mechanisms of live viral vaccine transfer from mother to fetus. Pregnancy-induced changes to the maternal immune system, effects of maternal infection on neonatal immunity, and the role of the placenta in transmission of infection and passive immunity to the fetus are incompletely understood. The aim of this paper is to review available data pertaining to newer vaccines such as the pandemic H1N1 and HPV vaccines in pregnancy, the role of Fc receptors in active transport of immunoglobulin across the placenta, and cytokine activity during maternal infection and after vaccination. We will also discuss potential areas for future research.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fox</LastName><ForeName>Karin A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Department of Obstetrics and Gynecology, University of Texas Medical Branch at Galveston, Galveston, TX 77550, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Theiler</LastName><ForeName>Regan</ForeName><Initials>R</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>K12 HD001269</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Curr Pharm Biotechnol</MedlineTA><NlmUniqueID>100960530</NlmUniqueID><ISSNLinking>1389-2010</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007252">Influenza Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014613">Vaccines, Attenuated</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007252" MajorTopicYN="N">Influenza Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008431" MajorTopicYN="Y">Maternal-Fetal Exchange</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011251" MajorTopicYN="N">Pregnancy Complications, Infectious</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014613" MajorTopicYN="N">Vaccines, Attenuated</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2010</Year><Month>04</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2010</Year><Month>11</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2011</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2011</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">21480828</ArticleId><ArticleId IdType="pii">BSP/CPB/E-Pub/00095-12-1</ArticleId><ArticleId IdType="doi">10.2174/138920111795471001</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001041 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001041 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= PandemieGrippaleV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:21480828
|texte= Vaccination in pregnancy.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:21480828" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a PandemieGrippaleV1
| This area was generated with Dilib version V0.6.34. |  |